Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models

Journal of Controlled Release(2020)10.1016/j.jconrel.2020.05.046Source: DataRank Database

DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models is a research paper published in Journal of Controlled Release (2020). On theSindex it has a DataRank of 0.494. It has been cited 26 times.

N/A

0.494DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: greenTopics (15)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.494

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (16)

Julie A. Nicoll,Kelly M. Redmond ORCID,Peter Smyth,Michelle K. Greene ORCID,William J. McDaid

Live enrichment

PubMed:19162232

National Cancer Institute

Grant: R21CA234775

National Cancer Institute

Grant: R01CA198096

National Center for Advancing Translational Sciences

Grant: UL1TR001412

Department of Health & Social Care

Grant: STL/5010/14

Medical Research Council

Grant: 1598124

Medical Research Council

Grant: MC_PC_15013

Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium

National Institutes of Health

Grant: 5R01CA198096-05

Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium

National Institutes of Health

Grant: 5R21CA234775-02

Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development

National Institutes of Health

Grant: 5P30CA016056-40

Roswell Park Cancer Institute Cancer Center Support Grant

National Institutes of Health

Grant: 3UL1TR001412-08S3

Buffalo Clinical and Translational Research Center

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7429293

publisherhttps://api.elsevier.com/content/article/PII:S0168365920303230?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365920303230?httpAccept=text/plain

https://doi.org/10.1016/j.jconrel.2020.05.046

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429293

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Drug CarriersCASP8 and FADD-Like Apoptosis Regulating Protein610Apoptosisname=SDG 3 - Good Health and Well-beingPancreatic NeoplasmsReceptors, TNF-Related Apoptosis-Inducing LigandCell Line, Tumor/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingHumansNanoparticles/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being

Sustainable Development Goals

SDG 3: 3. Good health